drugset / Trial / NCT04407234
A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide
NaSingle-groupOpen-labelBasic science
Summary
The purpose of this study is to learn more about how tirzepatide affects stomach emptying in overweight/very overweight participants. Participants include those without diabetes and those with type 2 diabetes. The study will last about 13 weeks for each participant, including screening.
Timeline
- Start
- 2020-09-15
- Primary completion
- 2021-01-07
- Completion
- 2021-01-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tirzepatide | Peptide | 15 mg | Subcutaneous |
| Background | Acetaminophen | Small molecule | 160 mg | Oral |